QTREX Quantum is the old Inspira medical-device issuer after a spring rename and an April purchase of Nano Dimension's additively manufactured electronics lines. The equity now trades as a quantum-and-defense hardware story, even though the last audited year is still a near-zero-revenue medical print. The debate is whether system placements convert into recognized sales before the next equity raise. A reader who stops at the ticker change misses that the legal entity, the auditor's going-concern language, and the cash-burn habit all predate the new brand.
Two institutional placements of $10 million each in May and August refilled the till after a going-concern paragraph in the last audited accounts. The acquired electronics and micro-printing lines produced just under $6 million of sales in that year. Direct costs ran about $17 million higher than those sales. An early September install at one of Israel's largest defense houses is the first physical proof of the new story. Later phases still need fresh contracts, and the partner's name stays confidential. Cash from the two raises buys time. It does not prove that the factory can cover its own cost base.
Medical revenue in the last audited year was $289 thousand. The operating loss was $13 million. The mid-year financial package has not appeared on the public record as of this note. The Fortune 500 system order and the defense install are the events that have to show up as booked revenue if the rename is more than a financed narrative. Until that print arrives, the market is paying for placements, exclusivity language, and two institutional checks rather than for a demonstrated run rate.